DOTS and drug resistance: a silver lining to a darkening cloud

Int J Tuberc Lung Dis. 1999 Jan;3(1):1-3.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Botswana / epidemiology
  • Comorbidity
  • Drug Resistance, Microbial
  • Global Health
  • HIV Infections / epidemiology
  • Humans
  • Incidence
  • Mycobacterium tuberculosis / drug effects
  • Patient Compliance*
  • Prevalence
  • Program Development
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Tuberculosis, Multidrug-Resistant / prevention & control
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / epidemiology*
  • Tuberculosis, Pulmonary / prevention & control

Substances

  • Antitubercular Agents